Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists

Blood

Volumn 97, Issue 5, 2001, Pages 1483-1490

  Mencacci, Antonella ^b   Perruccio, Katia ^b   Bacci, Angela ^b   Cenci, Elio ^b   Benedetti, Roberta ^b   Martelli, Massimo F ^b   Bistoni, Francesco ^b   Coffman, Robert ^b   Velardi, Andrea ^b   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNGUS GROWTH; FUNGUS IMMUNITY; INFECTION SENSITIVITY; LYMPHOCYTE DEPLETION; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 0035282931     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1483     Document Type: Article

References (45)

1. Fungal infections after bone marrow transplant
2. Infections in bone marrow transplant recipients
3. The potential role of cytokine therapy for fungal infections in patients with cancer: Is recovery from neutropenia all that is needed?
4. Chronic systemic candidiasis
5. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
6. Host defense against oropharyngeal and vaginal candidiasis: Site-specific differences
7. Specific and non-specific immunity to Candida albicans: A lesson from genetically modified animals
8. ATH1-TH2-like switch in candidiasis: New perspectives for therapy
9. Biological role of helper T-cell subsets in candidiasis
10. Immunity to Candida albicans: Th1, Th2 cells and beyond
11. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
12. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells
13. Tolerance induction by 'megadose' transplants of CD34+ stem cells: A new option for leukemia patients without an HLA-matched donor
14. Infections in adults undergoing unrelated donor bone marrow transplantation
15. Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins
16. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice
17. Quantitative analysis of T helper 1, T helper 2: And inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: Relationship with the occurrence of acute graft-versus-host disease
18. CD4+ subset expression in murine candidiasis: Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance
19. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development
20. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and independent pathways
21. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans
22. L. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: Implications for initiation of Th immunity in vitro and in vivo
23. The T cell response to fungi
24. Neutrophils production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice
25. Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2: Effect on T helper celt development
26. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
27. Long-term persistence of transferred PPD reactive T cells after allogeneic bone marrow transplantation
28. Imbalances within peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell population in the reconstitution phase after human bone marrow transplantation
29. Analysis of T cell repopulation after allogeneic marrow transplantation: Significant differences between recipients of T cell depleted and unmanipulated grafts
30. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation
31. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire
32. T-cell regeneration: All repertoires are not created equal
33. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from donor
34. Studies on transfer of varicell-zoster-virus specific T-cell immunity from bone marrow donor recipient
35. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients
36. The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation
37. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
38. Immune reconstitution following allogeneic peripheral blood stem cell transplants
39. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host diseases
40. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation
41. Significance of interleukin 10 for acute graft versus host disease in children and adolescents after allogeneic bone marrow transplantation
42. Association between interleukin-4-producing T lymphocyte frequencies and reduced risk of graft-versus-host disease
43. Bone marrow NK1.1(-) and NK1.1 (+)T cells reciprocally regulate acute graft versus host diseases
44. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice
45. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts